FDA meeting on abuse-deterrent opioids

FDA will hold a public meeting in Silver Spring, Md., on Oct. 30-31 to discuss the development, assessment, and regulation of abuse-deterrent opioid medications. The meeting will focus on scientific and technical issues related to the development and in vitro assessment of such drugs, and FDA's approach to the benefit-risk assessment of all opioid treatments. ...